Table 2.
Summary of results of MDES calculations
| Measure | Population | MDES | Time |
|---|---|---|---|
| ADAS-Cog11 | CN | ||
| EMCI | |||
| LMCI | 41% | 3 years | |
| AD | 35% | 2 years | |
| ADAS-Cog13 | CN | 89% | 6 years |
| EMCI | |||
| LMCI | 42% | 3 years | |
| AD | 34% | 2 years | |
| MMSE | CN | ||
| EMCI | 99% | 4 years | |
| LMCI | 34% | 3 years | |
| AD | 35% | 2 years | |
| MOCA | CN | ||
| EMCI | |||
| LMCI | 89% | 3 years | |
| AD | 76% | 2 years | |
| Hippocampus | CN | 35% | 6 years |
| EMCI | 34% | 5 years | |
| LMCI | 21% | 6 years | |
| AD | 54% | 2 years | |
| Whole brain | CN | ||
| EMCI | |||
| LMCI | |||
| AD | |||
| CDRSB | CN | 66% | 4 years |
| EMCI | |||
| LMCI | 28% | 2 years | |
| AD | 30% | 2 years | |
| FAQ | CN | 96% | 6 years |
| EMCI | 81% | 4 years | |
| LMCI | 27% | 3 years | |
| AD | 28% | 2 years |
Empty rows indicate no effect can be detected over a 6 year trial